Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Previously Published Works bannerUCSF

Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions.

  • Author(s): Gillette, William K;
  • Esposito, Dominic;
  • Abreu Blanco, Maria;
  • Alexander, Patrick;
  • Bindu, Lakshman;
  • Bittner, Cammi;
  • Chertov, Oleg;
  • Frank, Peter H;
  • Grose, Carissa;
  • Jones, Jane E;
  • Meng, Zhaojing;
  • Perkins, Shelley;
  • Van, Que;
  • Ghirlando, Rodolfo;
  • Fivash, Matthew;
  • Nissley, Dwight V;
  • McCormick, Frank;
  • Holderfield, Matthew;
  • Stephen, Andrew G
  • et al.

Published Web Location

https://doi.org/10.1038/srep15916
Abstract

Prenylated proteins play key roles in several human diseases including cancer, atherosclerosis and Alzheimer's disease. KRAS4b, which is frequently mutated in pancreatic, colon and lung cancers, is processed by farnesylation, proteolytic cleavage and carboxymethylation at the C-terminus. Plasma membrane localization of KRAS4b requires this processing as does KRAS4b-dependent RAF kinase activation. Previous attempts to produce modified KRAS have relied on protein engineering approaches or in vitro farnesylation of bacterially expressed KRAS protein. The proteins produced by these methods do not accurately replicate the mature KRAS protein found in mammalian cells and the protein yield is typically low. We describe a protocol that yields 5-10 mg/L highly purified, farnesylated, and methylated KRAS4b from insect cells. Farnesylated and methylated KRAS4b is fully active in hydrolyzing GTP, binds RAF-RBD on lipid Nanodiscs and interacts with the known farnesyl-binding protein PDEδ.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View